Clinical Trial

CorEvitas Rheumatoid Arthritis (RA) Drug Safety & Effectiveness Registry

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for RA in a cohort of patients cared for by rheumatologists across North America. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2011-07-25; most recent amendment 2025-09-29.
Status change: Recruiting → Enrolling by Invitation 2025-09-29
Status change: Enrolling by Invitation → Recruiting 2024-07-15
Trial Details
NCT Number NCT01402661
Lead Sponsor CorEvitas
Collaborators: University of Massachusetts, Worcester, University of Alabama at Birmingham, Brigham and Women's Hospital
Conditions Rheumatoid Arthritis
Enrollment 91,758 participants
Start Date 2002-02
Primary Completion 2100-12 (estimated)
Study Completion 2100-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-02